Pinpoint Therapeutics, Inc. (“Pinpoint”), a privately held biopharmaceutical company focused on the development of novel autophagy inhibitors to treat cancer, announced today that it has raised $1 million in debt financing led by Kairos Ventures of Beverly Hills, California.